Trials / Completed
CompletedNCT01076972
Drug Use Investigation of Kaletra
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,184 (actual)
- Sponsor
- Abbott · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This non-interventional, post-marketing observational study was conducted to obtain data, such as safety and effectiveness, from the use of lopinavir/ritonavir (Kaletra) in clinical practice and investigate the necessity to conduct a follow-up post-marketing clinical study in Japan.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lopinavir/ritonavir (Kaletra) | Lopinavir/ritonavir evaluated separately in patients who were naive to previous antiretroviral treatment and those who were not. |
Timeline
- Start date
- 2000-12-01
- Primary completion
- 2010-12-01
- Completion
- 2010-12-01
- First posted
- 2010-02-26
- Last updated
- 2012-03-01
- Results posted
- 2012-03-01
Locations
29 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT01076972. Inclusion in this directory is not an endorsement.